Unity Biotechnology | 10-Q: Quarterly report
Unity Biotechnology | 8-K: UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
Unity Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Ghosh Anirvan
Unity Biotechnology | ARS: Annual Report to Security Holders
Unity Biotechnology | DEFA14A: Others
Unity Biotechnology | DEF 14A: Definitive information statements
Unity Biotechnology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Unity Biotechnology | 10-K: Annual report
Unity Biotechnology | 8-K: UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
Unity Biotechnology | NT 10-K: Others
Unity Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen Alexander Hieu
Unity Biotechnology | 8-K: Current report
Unity Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alyeska Investment Group, L.P.(9.99%),Alyeska Fund GP, LLC(9.99%), etc.
Unity Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Ghosh Anirvan
Unity Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Ghosh Anirvan
Unity Biotechnology | EFFECT: Others
Unity Biotechnology | 424B3: Prospectus
Unity Biotechnology | CORRESP: CORRESP
Unity Biotechnology | UPLOAD: Others
Unity Biotechnology | S-3: Registration statement for specified transactions by certain issuers
No Data